Immunogenicity and safety of a tetanus-diphtheria vaccine and a 13-valent pneumococcal conjugate vaccine after concomitant vaccination in ≥ 50-year-old adults

Overview of attention for article published in BMC Infectious Diseases, December 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

policy: 1 policy source

twitter: 2 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 23 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 99 followers.

@LiamSchubel https://t.co/wiZj7jQAIi https://t.co/lpdRCOp7sK https://t.co/j8cf36tVjD https://t.co/PyvfeplsN4 https://t.co/0YO5TNPqHL These were some of the top results of of 4,457 clinical trials when I searched "vaccine safety" under the parameters "1990-

04 Dec 2020

Reply Repost Favourite

Immunogenicity and safety of a tetanus-diphtheria vaccine and a 13-valent pneumococcal conjugate vaccine after concomitant vaccination in ≥ 50-year-old adults https://t.co/Rz7uZkFhzI

06 Dec 2018

Reply Repost Favourite